SE352811B - - Google Patents

Info

Publication number
SE352811B
SE352811B SE07221/71A SE722171A SE352811B SE 352811 B SE352811 B SE 352811B SE 07221/71 A SE07221/71 A SE 07221/71A SE 722171 A SE722171 A SE 722171A SE 352811 B SE352811 B SE 352811B
Authority
SE
Sweden
Application number
SE07221/71A
Inventor
E Ryde
J Ekstedt
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE07221/71A priority Critical patent/SE352811B/xx
Priority to US256243A priority patent/US3863633A/en
Priority to CA142,946A priority patent/CA971881A/en
Priority to AU42916/72A priority patent/AU466574B2/en
Priority to FR7219472A priority patent/FR2140114B1/fr
Priority to GB2576272A priority patent/GB1360927A/en
Priority to DE19722226940 priority patent/DE2226940A1/de
Publication of SE352811B publication Critical patent/SE352811B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE07221/71A 1971-06-04 1971-06-04 SE352811B (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE07221/71A SE352811B (ja) 1971-06-04 1971-06-04
US256243A US3863633A (en) 1971-06-04 1972-05-24 Composition containing a substance showing a topical effect on the eye, and a method of preparing the same
CA142,946A CA971881A (en) 1971-06-04 1972-05-25 Composition containing a substance showing a topical effect on the eye, and a method of preparing the same
AU42916/72A AU466574B2 (en) 1971-06-04 1972-05-31 A composition containing a substance showing a topical effect onthe eye anda method of preparing same
FR7219472A FR2140114B1 (ja) 1971-06-04 1972-05-31
GB2576272A GB1360927A (en) 1971-06-04 1972-06-02 Composition containing a substance showing a topical effect on the eye and a method of preparing same
DE19722226940 DE2226940A1 (de) 1971-06-04 1972-06-02 Mittel zur Augenbehandlung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE07221/71A SE352811B (ja) 1971-06-04 1971-06-04

Publications (1)

Publication Number Publication Date
SE352811B true SE352811B (ja) 1973-01-15

Family

ID=20270768

Family Applications (1)

Application Number Title Priority Date Filing Date
SE07221/71A SE352811B (ja) 1971-06-04 1971-06-04

Country Status (7)

Country Link
US (1) US3863633A (ja)
AU (1) AU466574B2 (ja)
CA (1) CA971881A (ja)
DE (1) DE2226940A1 (ja)
FR (1) FR2140114B1 (ja)
GB (1) GB1360927A (ja)
SE (1) SE352811B (ja)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179497A (en) * 1973-12-17 1979-12-18 Merck & Co., Inc. Solid state ophthalmic medication
US4003991A (en) * 1974-08-27 1977-01-18 National Patent Development Corporation Ophthalmic formulation
US4183356A (en) * 1975-06-05 1980-01-15 Merck & Co., Inc. Ophthalmic applicator device
NL188266C (nl) * 1975-07-29 1992-05-18 Merck & Co Inc Werkwijze ter bereiding van een oogheelkundig inplantaat.
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
JPS54145207A (en) * 1978-04-30 1979-11-13 Agency Of Ind Science & Technol High viscosity eye lotion
US4287175A (en) * 1978-06-22 1981-09-01 Merck & Co., Inc. Contact lens wetting agents
US4281654A (en) * 1980-04-07 1981-08-04 Alza Corporation Drug delivery system for controlled ocular therapy
US4432964A (en) * 1981-08-24 1984-02-21 Alza Corporation Topical composition containing steroid in two forms released independently from polymeric carrier
US4730013A (en) * 1981-10-08 1988-03-08 Merck & Co., Inc. Biosoluble ocular insert
PT75625B (en) * 1981-10-08 1985-12-09 Merck & Co Inc Process for preparing biosoluble ocular insert
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
US5229128A (en) * 1986-06-11 1993-07-20 Haddad Heskel M Drug delivery ophthalmic insert and method of preparing same
JPH01308232A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 固型医薬およびその製造法
FR2690846B1 (fr) * 1992-05-05 1995-07-07 Aiache Jean Marc Forme galenique pour administration oculaire et procede de preparation.
US5948822A (en) 1996-12-17 1999-09-07 Lidak Pharmaceuticals Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
CA2414674A1 (en) * 2000-07-13 2002-01-24 Pharmacia Corporation Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
AR031135A1 (es) 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
US20030220376A1 (en) * 2001-08-10 2003-11-27 Pharmacia Corporation Methods for treating carbonic anhydrase mediated disorders
EA200400535A1 (ru) * 2001-10-16 2005-06-30 Аванир Фармасютикалз ПОДАВЛЕНИЕ ВИРУСОВ n-ДОКОСАНОЛОМ
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
WO2014124458A1 (en) 2013-02-11 2014-08-14 The Regents Of The University Of California Compositions and methods for treating neurodegenerative diseases
EP2970145B1 (en) 2013-03-11 2020-05-06 The Broad Institute, Inc. Compounds and compositions for the treatment of cancer
CA2939219C (en) 2014-02-11 2023-02-28 Mitokinin Llc Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
WO2016172712A2 (en) 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US11382909B2 (en) 2014-09-05 2022-07-12 Sydnexis, Inc. Ophthalmic composition
JP2018521000A (ja) 2015-05-29 2018-08-02 シドネキシス，インク． Ｄ２ｏで安定化された医薬製剤
SI3344248T1 (sl) 2015-09-02 2022-07-29 Trevena, Inc. 6-členske aza-heterociklične spojine za modulacijo, ki vsebujejo delta-opioidne receptorje, metode uporabe in izdelave
CA3052479A1 (en) 2017-02-17 2018-08-23 Trevena, Inc. 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
BR112019016827A2 (pt) 2017-02-17 2020-04-07 Trevena Inc compostos moduladores de receptor delta-opioide contendo aza-heterocíclico com 5 membros, métodos de uso e produção dos mesmos
CA3067695A1 (en) 2017-06-21 2018-12-27 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
US11471426B2 (en) 2019-10-16 2022-10-18 American River Nutrition, Llc Compositions comprising quinone and/or quinol and methods of preparations and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US273410A (en) * 1883-03-06 Gelatine eye-disk
US108034A (en) * 1870-10-04 Improvement in putting up medicines
US3075527A (en) * 1960-06-02 1963-01-29 Chemway Corp Sterile medicated strips
US3150045A (en) * 1962-04-16 1964-09-22 Allergan Pharma Re-epithelization process
US3311577A (en) * 1965-03-29 1967-03-28 Burton Parsons Chemicals Inc Underwater contact lens solution
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
US3640741A (en) * 1970-02-24 1972-02-08 Hollister Inc Composition containing gel

Also Published As

Publication number Publication date
US3863633A (en) 1975-02-04
FR2140114A1 (ja) 1973-01-12
AU4291672A (en) 1973-12-06
CA971881A (en) 1975-07-29
FR2140114B1 (ja) 1976-03-05
DE2226940A1 (de) 1972-12-14
AU466574B2 (en) 1975-10-30
GB1360927A (en) 1974-07-24

Similar Documents

Publication Publication Date Title
FR2140114B1 (ja)
AR196074A1 (ja)
AU2658571A (ja)
AU2691671A (ja)
AU2684071A (ja)
AU2564071A (ja)
AU2742671A (ja)
AU2894671A (ja)
AU2941471A (ja)
AU2952271A (ja)
AU3005371A (ja)
AU3109071A (ja)
AU467721B2 (ja)
AU2740271A (ja)
AU2837671A (ja)
AU2577671A (ja)
AU3038671A (ja)
AU3025871A (ja)
AU2588771A (ja)
AU2963771A (ja)
AU2654071A (ja)
AU2669471A (ja)
AU2940971A (ja)
AU2938071A (ja)
AU2930871A (ja)